Lipocine's total assets for Q3 2025 were $16.07M, a decrease of -13.48% from the previous quarter. LPCN total liabilities were $1.93M for the fiscal quarter, a 33.29% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.